
BlueGem supports PCG for Cosmetic Skin Clinic bolt-on
BlueGem Capital Partners has supported portfolio company Private Clinic Group (PCG), a UK-headquartered provider of cosmetic surgery, in the acquisition of The Cosmetic Skin Clinic.
The consolidated group will provide both invasive and non-invasive cosmetic treatments and have a combined turnover of around £30m with an EBITDA margin of around 20%, according to a statement.
BlueGem acquired PCG in 2008 in a deal estimated by Unquote Data to have been in the £25-50m enterprise value range. Under the GP's tenure, the business has opened six new clinics and bolted on Hans Place, Regency Medical and Aurora Clinics. During that time, it has increased its revenues from £4m to around £18m, according to the statement.
Company
Founded in 2000 and headquartered in Stoke Poges, Buckinghamshire, The Cosmetic Skin Clinic operates one site in Buckingham and one in London. It provides non-surgical treatments for the face, body and skin, some of which use ultrasound and radio-frequency technology.
People
BlueGem – Emilio Di Spiezio Sardo (co-founder, partner); Sarah Walker (director).
Private Clinic Group – Valentina Petrone (CEO).
The Cosmetic Skin Clinic – Tracy Mountford (founder).
Advisers
Equity – Epic (corporate finance); McDermott Will & Emery (legal); Grant Thornton (financial due diligence); Marlborough Partners (debt advisory).
Company (The Cosmetic Skin Clinic) – Farrer & Co (legal); Glazers (tax).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater